DK0901379T3 - Type 2-kemokinbindende proteiner og metoder til anvendelse deraf - Google Patents

Type 2-kemokinbindende proteiner og metoder til anvendelse deraf

Info

Publication number
DK0901379T3
DK0901379T3 DK97926647T DK97926647T DK0901379T3 DK 0901379 T3 DK0901379 T3 DK 0901379T3 DK 97926647 T DK97926647 T DK 97926647T DK 97926647 T DK97926647 T DK 97926647T DK 0901379 T3 DK0901379 T3 DK 0901379T3
Authority
DK
Denmark
Prior art keywords
type
chemokine binding
methods
binding proteins
poxviruses
Prior art date
Application number
DK97926647T
Other languages
English (en)
Inventor
D Grant Mcfadden
Alexandra Lucas
Original Assignee
Univ Alberta
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Alberta filed Critical Univ Alberta
Application granted granted Critical
Publication of DK0901379T3 publication Critical patent/DK0901379T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
DK97926647T 1996-05-22 1997-05-21 Type 2-kemokinbindende proteiner og metoder til anvendelse deraf DK0901379T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1813796P 1996-05-22 1996-05-22
PCT/US1997/008590 WO1997044054A2 (en) 1996-05-22 1997-05-21 Type-2 chemokine binding proteins and methods of use therefor

Publications (1)

Publication Number Publication Date
DK0901379T3 true DK0901379T3 (da) 2000-12-27

Family

ID=21786445

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97926647T DK0901379T3 (da) 1996-05-22 1997-05-21 Type 2-kemokinbindende proteiner og metoder til anvendelse deraf

Country Status (21)

Country Link
EP (1) EP0901379B1 (da)
JP (1) JP2000511535A (da)
KR (1) KR20000015895A (da)
CN (1) CN1226171A (da)
AT (1) ATE196091T1 (da)
AU (1) AU3136197A (da)
BR (1) BR9710028A (da)
CA (1) CA2256568A1 (da)
CZ (1) CZ378998A3 (da)
DE (1) DE69703040T2 (da)
DK (1) DK0901379T3 (da)
ES (1) ES2152095T3 (da)
GR (1) GR3034805T3 (da)
HK (1) HK1017622A1 (da)
IL (1) IL127166A0 (da)
NO (1) NO985412L (da)
NZ (1) NZ333456A (da)
PL (1) PL330149A1 (da)
PT (1) PT901379E (da)
TR (1) TR199802392T2 (da)
WO (1) WO1997044054A2 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19853487A1 (de) 1998-11-19 2000-05-25 Fumapharm Ag Muri Verwendung von Dialkylfumaraten
GB9916703D0 (en) * 1999-07-16 1999-09-15 Alcami Antonio Viral protein binding compositions and methods
AU2001261738A1 (en) * 2000-05-17 2001-11-26 London Health Sciences Centre Compositions and methods for promoting immunosuppression
JP2004515471A (ja) 2000-09-08 2004-05-27 グリフォン セラピューティクス，インコーポレーテッド 合成赤血球産生刺激タンパク質
US6894155B2 (en) 2000-10-11 2005-05-17 Viron Therapeutics Nucleic acid molecules and polypeptides for immune modulation
ES2287192T3 (es) 2000-12-04 2007-12-16 Viron Therapeutics, Inc. Proteina inmunomoduladora derivada del virus de tumor del mono de yaba.
US7718368B2 (en) 2000-12-04 2010-05-18 Viron Therapeutics Inc. Immunomodulatory protein and useful embodiments thereof
DE10162869A1 (de) * 2001-12-20 2003-07-31 Alexander Cherkasky Invasive lineare halb-zyklische und zyklische Systeme zur Herauslockung der Krankheitserreger
GB0304531D0 (en) * 2003-02-27 2003-04-02 Isis Innovation Treatment
CA2524534C (en) * 2003-05-15 2012-12-11 Sek Chung Fung Methods and compositions for the prevention and treatment of sepsis
WO2005023241A1 (en) 2003-09-09 2005-03-17 Fumapharm Ag The use of fumaric acid derivatives for treating cardiac insufficiency, and asthma
PL2653873T3 (pl) 2007-02-08 2022-08-22 Biogen Idec Ma Inc. Kompozycje i zastosowania do leczenia stwardnienia rozsianego
CN113234137B (zh) * 2021-06-21 2022-02-25 华中农业大学 分离自草鱼的CXCL20a蛋白在作为抗菌肽中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06508502A (ja) * 1991-03-29 1994-09-29 イミュネックス・コーポレーション 単離されたウイルス蛋白質サイトカイン拮抗薬
DE69628838T2 (de) * 1995-04-19 2004-05-06 The John P. Robarts Research Institute, London Chemokin bindendes protein und verfahren zu seiner verwendung
EP0862449A4 (en) * 1995-09-29 1998-11-11 Immunex Corp CHEMOKIN INHIBITOR

Also Published As

Publication number Publication date
BR9710028A (pt) 1999-08-10
EP0901379A2 (en) 1999-03-17
EP0901379B1 (en) 2000-09-06
ES2152095T3 (es) 2001-01-16
DE69703040D1 (de) 2000-10-12
KR20000015895A (ko) 2000-03-15
TR199802392T2 (xx) 1999-02-22
IL127166A0 (en) 1999-09-22
PT901379E (pt) 2001-02-28
GR3034805T3 (en) 2001-02-28
NZ333456A (en) 2000-08-25
HK1017622A1 (en) 1999-11-26
ATE196091T1 (de) 2000-09-15
CN1226171A (zh) 1999-08-18
PL330149A1 (en) 1999-04-26
NO985412L (no) 1999-01-20
DE69703040T2 (de) 2001-05-03
JP2000511535A (ja) 2000-09-05
AU3136197A (en) 1997-12-09
CA2256568A1 (en) 1997-11-27
NO985412D0 (no) 1998-11-20
WO1997044054A2 (en) 1997-11-27
WO1997044054A3 (en) 1998-05-14
CZ378998A3 (cs) 1999-07-14

Similar Documents

Publication Publication Date Title
DK0840615T3 (da) Kemokin-bindende protein og fremgangsmåder til anvendelse deraf
DK0901379T3 (da) Type 2-kemokinbindende proteiner og metoder til anvendelse deraf
IL161016A (en) Polypeptides capable of ang-2 binding
DE60140773D1 (de) Polypeptide zur Bindung an das B-Lymphozyten-stimulatorische Protein (BLyS)
ATE226633T1 (de) Bindungsdomänen in notch- und delta-proteinen
DK2233498T3 (da) Kallikrein-inhiberende Kunitz-domæneproteiner og nukleinsyrer, der koder for disse
DK1149905T3 (da) Fremgangsmåder og præparat til polypeptidteknologi
BR0009206A (pt) Isolamento e análise de proteina
DE69833014D1 (de) Menschliche toll homologen
DK1017715T3 (da) Kimært polypeptid der omfatter fragment B af shiga-toksin og peptider af terapeutisk interesse
DE69531958D1 (de) (1-3)-beta-d-glukon-bindungsprotein, antikörper der dieses protein erkennt undverwendung des proteins und antikörper
DK0948604T3 (da) Screeningsmetoder for forbindelser som binder til PYK2-polypeptidet
DK41590A (da) Forbedrede protein c-molekyler samt fremgangsmaade til fremstilling og aktivering af samme
ATE159546T1 (de) Allergene aus roggenspreupollen
DK1387854T3 (da) SFRP og peptidmotiver som interagerer med SFRP og fremgangsmåder til anvendelse deraf
DK0968288T3 (da) z219a, en human homolog til 2-19 protein
ATE301194T1 (de) Beta-defensine
WO1997044451A3 (en) Vasoactive amine binding molecules
PT723552E (pt) Oligopeptidos derivados de fragmentos de proteina reactiva c
DK0792291T3 (da) Protein, der påvirker KATP-kanaler
DE3888715T2 (de) Reg-Gen und dadurch kodiertes Protein.
DK0999849T3 (da) Anvendelse af LBP til sepsisbehandling
EA199900663A1 (ru) Новые белки, связывающиеся с рецептором 1 интерферона, кодирующая их днк и способы модуляции клеточного ответа на интерфероны
WO1991013984A3 (en) Interleukin-4 binding proteins
MX9701904A (es) Proteinas de enlace de pka novedosas y usos de las mismas.